An attempt was made to unravel further the mechanism by which high dietary concentrations of ascorbic acid influence copper metabolism. The addition of ascorbic acid to the diet of rats caused about a twofold increase in plasma ascorbate concentrations and reduced group mean plasma and tissue concentrations of Cu. The effect of 10 g ascorbic acid/kg diet was greater than that of 1 g/kg. Ascorbic acid feeding reduced blood haemoglobin concentrations and packed cell volume values. Dietary ascorbic acid caused a significant decrease in apparent Cu absorption from the intestine. Ascorbate, intravenously administered together with "Cu, caused an increase in "Cu in the liver. Ascorbate, at concentrations occurring in plasma after ascorbic acid feeding, promoted the uptake of "Cu by isolated hepatocytes. Thus, ascorbate stimulated the efficiency of hepatic uptake of Cu. Ascorbate, intravenously administered together with "Cu, stimulated accumulation of "Cu in bile of rats with a bile duct cannula. In rats fed on ascorbic acid, intravenously administered "CU was recovered in bile at increased rates. Dietary ascorbic acid enhanced the recovery of intraperitoneally administered "CU in faeces. The ascorbateinduced stimulation of biliary "CU excretion may reflect an increased hepatic uptake of "CU and be caused by an increased specific activity of Cu in liver pools. It is suggested that dietary ascorbic acid reduces tissue Cu concentrations primarily by interfering with intestinal Cu absorption. Ascorbate increases the efficiency of hepatic uptake of Cu, but this effect may not be causatively related with the reduced tissue Cu concentrations after ascorbic acid feeding.
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In laboratory animals, high intakes of ascorbic acid cause reduced plasma and liver concentrations of copper and decreased plasma activities of ceruloplasmin (EC 1 .16.3.1) (Hunt et al. 1970; Milne & Omaye, 1980; Smith & Bidlack, 1980; Milne et al. 1981; Johnson & Murphy, 1988) . In addition, rats fed on large amounts of ascorbic acid develop anaemia, which may be the result of ascorbate-induced Cu deficiency (Johnson & Murphy, 1988) . In humans, ascorbic acid supplementation may induce decreased Cu concentrations and ceruloplasmin activities in serum (Finley & Cerklewski, 1983; Jacob et al. 1987; Milne et al. 1988) .
In rats fed on ascorbic acid, whole-body retention of orally administered 64Cu was depressed (Van Campen & Gross, 1968) and the apparent efficiency of Cu absorption reduced (Johnson & Murphy, 1988) . The disappearance of 64Cu from ligated intestinal segments was depressed by the addition of ascorbate to the lumen (Van Campen & Gross,
G . J . V A N D E N BERG A N D A. C . B E Y N E N 1968
). Simultaneous oral administration of "Cu and ascorbate increased the recovery of fi4Cu in faeces within 1 d when compared with the administration of 64Cu alone (Van den Berg et al. 1990) . Thus, it is plausible that ascorbate impairs Cu absorption.
Post-absorptively, ascorbate may also influence Cu metabolism. After intraperitoneal administration of 64Cu, whole-body retention of 64Cu and specific activity of 64Cu in the liver were increased in rats fed on ascorbate (Van den Berg et al. 1990 ). This effect may relate to the reduced tissue Cu concentrations in rats fed on ascorbate, because in nutritionally Cu-deficient rats whole-body retention of intraperitoneally administered 'j4Cu was also increased ( Van den Berg et al. 1990 , 1991 . Further evidence supporting this concept comes from the observation that liver cells isolated from Cu-deficient rats have increased efficiency of Cu uptake (Van den Berg et al. 1991) . Thus, dietary ascorbic acid may have indirect effects, i.e. effects caused by ascorbate-induced decreased tissue Cu concentrations.
With the use of a human erythroleukemic cell line (K562 cells) it was shown that ascorbate enhances Cu transport from ceruloplasmin into the cells (Percival & Harris, 1989) . DiSilvestro & Harris (1981) have shown an enhancing effect of ascorbate, when administered together with Cu, on lysyl oxidase (EC 1 . 4 . 3 . 13) activity in chick aorta, a Cu-dependent enzyme extremely sensitive to changes in dietary Cu. These studies point to a direct effect of ascorbate. It may be caused by enhancement of Cu dissociation by reduction of Cu(I1) to Cu(I), which promotes the availability of Cu for cellular uptake (Van den Berg & Ettinger et a/. 1986 ). Thus, the indirect and direct effects of ascorbate on cellular Cu uptake are complementary.
To unravel further the metabolic basis for the reduced tissue Cu concentrations after ascorbic acid feeding, the influence of ascorbate on hepatic uptake and biliary excretion of Cu is of interest. Bile is the main route by which Cu leaves the body and, thus, biliary Cu excretion plays an important role in Cu homeostasis. We have carried out in vitro and in vivo experiments to study the effect of ascorbate on hepatic Cu metabolism. The previously-mentioned studies with rats (Van Campen & Gross, 1968; Johnson & Murphy, 1988; Van den Berg et al. 1990 ) have employed diets containing 10 g ascorbic acid/kg, which is equivalent to intakes of about 1 g ascorbic acid/kg body-weight. Compared with common doses of ascorbic acid supplementation in humans (Finley & Cerklewski, 1983; Jacob et a(. 1987 ) such intakes are unrealistically high, which might interfere with extrapolation of the rat findings to man. Therefore, we have studied not only the effects on Cu metabolism in rats of diets containing 10 g ascorbic acid/kg, but also those of diets containing 1 g ascorbic acid/kg. The effects of 1 g ascorbic acid/kg were studied using diets containing either recommended (National Research Council, 1978) or low amounts of Cu because in animals fed on a low-Cu diet the effects of ascorbic acid feeding may be more pronounced.
M A T E R I A L S A N D METHODS

Expt 1. Cu uptake by isolated rat hepatocytes
Male Wistar rats of the HSD/Cpb:WU strain (Harlan-CPB, Zeist) were used as hepatocyte donors. The rats were aged 10 weeks and had been fed on a commercial pelleted diet (SRMA"; Hope Farms, Woerden) and tap water ad lib. Hepatocytes were isolated by the collagenase (EC 3.4.24.3) perfusion method of Berry & Friend (1969) . Primary parenchymal cell cultures were obtained by selective attachment to collagenized plastic dishes (diameter, 60 mm) for 2 h at 37" in a Ham's F-10 medium (Ham, 1963) supplemented with fetal calf serum (120 ml/l). Various concentrations of ascorbate (L-ascorbate ; Merck, Darmstadt, Germany) and f i 4 C~ acetate (1 5 pmol Cu/l) were added to the medium. After various incubation periods at 37" the radioactive medium was aspirated and the cells were harvested and washed twice with Ham's F-10 before measurement of cellular 64Cu. Net Cu uptake by hepatocytes was expressed as ng Cu/mg cellular protein, and was corrected for non-specific Cu binding or uptake, or both, by subtracting cellular radioactivity determined after incubation of hepatocytes at 4" in parallel experiments. To test whether ascorbate interacts specifically with Cu uptake, 65ZnC1, uptake by hepatocytes was also measured. For this purpose, 65ZnC1, (12 pmol Zn/l; specific activity 35 TBq "Zn/g Zn; Radiochemical Centre, Amersham, UK) was added to the medium of parallel incubations.
E.xpt 2. Hepatic uptake and biliary excretion of 64Cu after intravenous administration of 64Cu with or without ascorbate Male Wistar rats, aged 10 weeks and weighing on average 250 g, were used. The rats had been fed on commercial pelleted diet and tap water ad lib. The animals were anaesthetized with pentobarbital sodium (60 mg/kg body-weight intraperitoneally ; NembutaP, Sanofi Sante Animale SA, Paris, France). The bile duct was cannulated as described elsewhere (Villalon et al. 1987) . Body temperature was kept at 37" with the use of a thermostaticallycontrolled heating lamp. At 15 min after collection of the first bile, 64Cu acetate (0.5 pg Cu) with or without 0.1 mg ascorbate in phosphate-buffered saline (9 g sodium chloride/l) was injected intravenously; a total volume of 0.25 ml was injected per animal. Bile was then collected for a period of 150 min after which the rats were killed by exposure to carbon dioxide. Blood was collected by aortic puncture and livers were removed. 64Cu was measured in bile, liver and carcass without liver.
Expt 3. Efect of a diet containing 10 g ascorbic acidlkg on Cu metabolism Male, specified-pathogen-free Wistar rats, aged about 3 weeks, were used. On arrival in the animal house they were kept, three animals in a cage, in wire-topped Makrolon-3 cages (UNO BV, Zevenaar) with a layer of sawdust as bedding. For 10 d they were fed ad lib. on a purified diet containing 5 mg Cu/kg. The diet was formulated according to the recommended nutrient requirements of rats (National Research Council, 1978) ; its composition is given in Table 1 . After the pre-experimental period of 10 d (day 0) the rats were divided into two groups consisting of six rats each. One group remained on the preexperimental diet and the other group was transferred to the diet containing 10 g ascorbic acid/kg (Table 1) .
On day 28 the animals received a single oral dose of "Cu acetate ( 5 pg Cu) and on day 35 an intraperitoneal injection of 64Cu acetate ( 5 p g Cu) in 0.25 ml sodium acetate buffer (0.05 mol/l, pH 5.4). After the administration of Y u , urine and faeces were collected during 3 d for determination of 64Cu, and f i 4 C~ whole-body measurements were extended over 96 h. True efficiency of Cu absorption was calculated according to Heth & Hoekstra (1965) .
On day 42, the bile duct was cannulated while under pentobarbital anaesthesia. After another 15 min, "Cu acetate (0.5 p,g Cu) was administered intravenously. Subsequently, bile was collected over a total period of 150 min. Then the rats were killed by exposure to CO, and livers excised. 64Cu in whole liver, body (minus liver) and total bile was measured and expressed as a percentage of the administered dose. Liver metallothionein, Cu in selected tissues, plasma ascorbate, packed cell volume, blood haemoglobin and plasma ceruloplasmin (as its oxidase activity) were determined.
Expt 4 . Efects of diets containing I g ascorbic acidlkg on Cu metabolism
Male Wistar rats aged about 3 weeks were used. All animals were fed on the purified diet containing 5 mg Cu/kg. After 10 d, on day 0 of the experimental period, the rats were divided into four groups of equal size so that group mean body-weights were similar. Each 2 Average values of six measurements.
group was randomly assigned to one of four experimental diets. The diets contained 5 mg Cu/kg with or without 1 g ascorbic acid/kg or 1 mg Cu/kg with or without 1 g ascorbic acid/kg. The former diet was identical to the pre-experimental diet. The composition of the diets is given in Table 1 . The experiment was carried out with three cohorts of twelve rats each, that is three rats per dietary group. The interval between the experiment with the first and second cohort was 1 week, and that between the second and third cohort was 16 weeks. During the experimental period (days 0-28) the rats were housed individually in metabolism cages (Techniplast Gazzada, Buguggiate, Italy). One batch of diet was used for the three cohorts. The diets, which were in powdered form, were stored at -20" until feeding. The concentration of ascorbic acid was checked before the study of each cohort.
From days 11 to 13 and days 24 to 26 urine and faeces of each rat were collected quantitatively. The tubes for collecting faeces and urine had been cleaned with 0.1 mol hydrochloric acid/l. Urinary and faecal Cu were analysed.
On day 24 each non-starved rat was injected intraperitoneally with 64Cu acetate (25 pg Cu/kg body-weight) and 64Cu whole-body retention was determined. Urine and faeces were collected during 3 d for determination of 64Cu.
On day 28 the animals were killed by exposure to CO,. Blood samples were taken by aortic puncture. Tissues were collected, weighed, and frozen at -20" until analysis. Plasma ascorbate, packed cell volume, blood haemoglobin and plasma ceruloplasmin were determined.
64Cu and radiochemical analyses 64Cu was obtained by irradiating a Cu wire (purity 99.999 YO ; Ventron, Karlsruhe, Germany) in a thermal neutron flux of 10"/m2 per s for 36 h in the reactor of the Interfaculty Reactor Institute of the Delft University of Technology. Following irradiation, the wire was dissolved in 25p1 nitric acid (undiluted) and diluted with sodium acetate There were significant effects of ascorbate, incubation period and interaction (two-way analysis of variance;
buffer (0.05 mol/l, pH 5.4) resulting in a final Cu concentration of 1 mg/ml. The specific activity of the 64Cu solution at the start of the experiments was 320 GBq 64Cu/g Cu (8.5 Ci/g). "Cu in urine, faeces, bile and tissues was determined by gamma counting (Philips Model PW4800 with a 3 x 3 inch sodium iodide crystal detector; overall efficiency of 6%).
"CCU whole-body retention was determined with a whole-body counter specially designed for rats (Van Barneveld & Van den Hamer, 1985) . The overall efficiency of this counter for "Cu was 14%. Whole-body counting of the animals was performed within 2 h postinjection and at regular intervals for another 96 h.
Chem icat analvses
Urine and faeces were pretreated for Cu analysis. Urine was acidified to pH 1 with 6 mol HCl/l, and centrifuged for 10min. The supernatant fraction was used for Cu analysis. Faeces were freeze-dried, ashed at 500" for 18 h and dissolved in 6 mol HCl/l. Tissues were freeze-dried and then digested with HNO, (Suprapur ; Merck, Darmstadt, Germany) and hydrogen peroxide (Aristar; BDH Chemicals, Poole, UK). The mixture consisted of 1 g tissue/l HN0,-H,O, (13:6, v/v). Feed samples were pretreated for Cu analysis as described for faeces. All Cu analyses were performed by flame atomic absorption spectrometry with the use of a Varian AA-475 (Varian Technotron, Springvale, Australia). The accuracy was evaluated by concurrent analysis of Standard Reference Material 1577 Bovine Liver (US National Institute of Standards and Technology, Gaithersburg, Maryland, USA). We found 156 (SE 3)pg Cu/g (n 6 runs), while the certified value was 158 pg Cu/g. Ascorbic acid in diet samples was quantified after extraction with 0.68 mol metaphosphoric acid/] by high-performance liquid chromatography (HPLC) with electrochemical detection (Yoshiura & Iriyama, 1986) . For the analysis of plasma ascorbate, plasma was mixed with 0.54 rnol metaphosphoric acid/] (1 :4, v/v) in order to precipitate proteins and to stabilize ascorbate (Parviainen et al. 1986) . Ascorbate was then determined by a HPLC method applying pre-column derivatization and spectrofluorometry (Speek et al. 1984) .
Ceruloplasmin in plasma was measured by its enzymic oxidase activity, using p-phenylenediamine as substrate. The p-phenylenediamine oxidase activity of rat ceruloplasmin was converted to a concentration of ceruloplasmin (g/l) as described by (1970) . Blood haemoglobin was measured spectrophotometrically as metcyanohaemoglobin at 540 nm using Lyse S (Coulter Electronics, Krefeld, Germany). Liver metallothionein was determined by the ' Cd-hem' method reported by Onosaka & Cherian (1981) .
Statistical analysis
The Kolmorgorov-Smirnov one-sample test was used to check normality of the data. For data distributed normally either Student's t test, one-way or two-way analysis of variance was applied to disclose statistically significant effects of treatments as indicated in the tables. Data not distributed normally were transformed logarithmically and then checked for homogeneity of variances (Cochran's C test) ; subsequently, statistically significant differences were evaluated as indicated previously for normally distributed data.
R E S U L T S
Expt 1. Cu uptake by isolated hepatocytes Hepatocytes accumulated 64Cu (Table 2 ) with time and this was a temperature-dependent process because at 4" Cu uptake rates were less than 5 % of those measured at 37" (values not shown). When ascorbate was added to the incubation medium a marked increase in "Cu uptake occurred which depended on the ascorbate concentration (Table 2) . On the other hand, the addition of ascorbate to the incubation medium (1000 ,umol/l) stimulated uptake of 65Zn by hepatocytes on average by 12 %, but this effect did not reach statistical significance.
Expt 2. Hepatic uptake and biliury excretion of 64Cu after intravenous administration of
64Cu without or with ascorbate Table 3 shows that rats injected with ascorbate accumulated more 'j4Cu in liver and excreted more in bile, whereas their remaining carcass contained less T u compared with controls.
Expt 3. E f e t t of a diet containing 10 g ascorbic acidlkg on Cu metabolism
The addition of ascorbic acid to the diet at a concentration of 10 g/kg caused a more than twofold increase in plasma ascorbate levels (Table 4) . Ascorbate did not influence bodyweight gain. Packed cell volume and blood haemoglobin concentrations were significantly reduced by ascorbate intake. Rats fed on ascorbic acid showed significantly decreased 
3.1
Mean values were significantly different from those of animals not given ascorbic acid (two-tailed Student's t test): * P < 0.05, ** P < 0.01, *** P < 0.001.
t For details of procedures, see p. 703. 4 As measured by its oxidase activity.
5 As pg Cu/g dry weight.
activities of plasma ceruloplasmin. Control values of ceruloplasmin-protein concentration correspond well with those reported by other workers (DiSilvestro et ul. 1988) . Ascorbic acid feeding lowered Cu concentrations in plasma, liver, kidney, heart, spleen, muscle and bone. Group mean concentrations of Cu in skin were also lowered by ascorbic acid intake, but this effect just failed to reach statistical significance. Whole-body retention of 64Cu after oral and intraperitoneal administration of "Cu is shown in Fig. 1 . Orally administered fi4Cu was not retained as efficiently as intraperitoneally injected "Cu. Biological half-lives of orally and intraperitoneally administered 64Cu were 4.7 (SE 0.3) d and 5.2 (SE 0.4) d (n 5 ) respectively for rats fed on the diet without ascorbic acid. The differences induced by ascorbic acid were not statistically significant. However, Cu retention, as indicated by whole-body "CU levels, was systematically higher in rats fed on ascorbic acid (Fig. 1) . Cu absorption, as calculated from the y intercept values after extrapolation of the linear part of the retention curves (42-96 h) for orally administered v.
injected "Cu, was 62 (SE 2) YO for control rats and 59 (SE 2) YO (n 5 ) for rats fed on ascorbic acid.
Ascorbic acid in the diet did not influence faecal and urinary excretion of orally administered "Cu (Table 5 ). The excretion of 64Cu in the faeces after intraperitoneal administration of "Cu was significantly decreased in rats fed on ascorbic acid. After intravenous administration of T u the amount of "Cu in the liver was similar for rats fed 
P < 0001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0001 P < 0.001 P < 0.001 1 Two-way analysis of variance; plasma and spleen Cu concentrations were subjected to ANOVA after log 5 As pg Cu/g dry weight.
transformation of the data.
on diets without or with ascorbic acid (Table 5 ). Biliary excretion of 64Cu was significantly increased by ascorbic acid feeding.
Expt 4 . Effects of diets containing I g ascorbic acidlkg on Cu metabolism
The addition of ascorbic acid to the diet at a concentration of 1 g/kg caused a significant increase in plasma ascorbate levels ( Table 6 ). Ascorbic acid tended to lower body-weight when fed in combination with the diet low in copper. Feed intakes were not influenced significantly by ascorbic acid or copper concentration of the diet (Table 6 ). Ascorbic acid reduced packed cell volume values and blood haemoglobin concentrations both in rats given diets with recommended and those with low Cu concentrations, the effect being somewhat more pronounced in the latter. Plasma ceruloplasmin (activity) was not influenced by ascorbate, but almost completely suppressed by low Cu intake, In rats fed on the diets with the recommended Cu concentration, high ascorbic acid intake induced decreased group mean Cu concentrations in plasma and liver. Likewise, group mean concentrations of Cu in other tissues were lowered by dietary ascorbic acid. Feeding the diets with the low Cu concentration resulted in markedly lowered Cu concentrations in all tissues. 6 Apparent absorption is expressed in absolute (intake -faecal output) and relative terms (100 x (intake -faecal All data were subjected to ANOVA after log transformation.
output)/intake). Table 8 . $ All data were subjected to ANOVA after log transformation.
Dietary ascorbic acid increased faecal loss of Cu both in rats fed on diets with recommended and those with low Cu concentrations (Table 7) . Cu in urine was not detectable. The absolute and percentage apparent absorption values of Cu were significantly decreased by dietary ascorbic acid. Low intake of Cu increased the apparent efficiency of Cu absorption.
Ascorbic acid in the diet significantly increased faecal excretion of intraperitoneally administered 64Cu in rats given the diet with the recommended Cu concentration, but did not influence urinary excretion of f i 4 C~ ( Table 8 ). The excretion of 64Cu in faeces and urine was significantly decreased in rats fed on the low-Cu diet; dietary ascorbic acid did not affect 64Cu excretion in these rats.
Whole-body retention of intraperitoneally administered 64Cu is shown in Fig. 2 . A significantly higher retention was found in rats fed on the low-Cu diets compared with rats fed on diets with the recommended Cu concentration. Biological half-lives of the administered 64Cu were 6.0 (SE 0.3) and 19.0 (SE 0.7) d (n 9) respectively for rats fed on the recommended and low-Cu diets without added ascorbic acid. For the rats fed on the diets containing ascorbic acid, these values were 5.0 (SE 0.3) and 20.0 (SE 0.7) d respectively. Thus, dietary ascorbic acid tended to diminish Cu retention in rats given the diet with recommended Cu concentration, but this effect was very small.
D I S C U S S I O N
The rat as model We have used the rat as a model to study the effects of ascorbic acid supplementation on Cu metabolism. It could be argued that the rat is not a suitable model because this animal species, unlike humans, can synthesize adequate amounts of this vitamin. The feeding of rats with diets enriched with ascorbic acid resulted in a significant increase in plasma ascorbate concentrations. These results indicate that in the rat ascorbate status can be modulated by ascorbic acid intake, which may imply that the rat is a suitable model to study the effects of ascorbic acid supplementation on Cu metabolism. This is further supported by the observation that ascorbic acid feeding reduces plasma Cu concentrations in both humans (Finley & Cerklewski 1983; Jacob et al. 1987; Milne et al. 1988 ) and rats (Johnson & Murphy, 1988; present study) .
Ascorbic acid and Cu status
Addition of ascorbic acid to diets with recommended Cu concentrations resulted in depressed plasma ceruloplasmin activity and decreased Cu concentrations in plasma and various tissues, especially liver. This agrees with findings of other studies using diets containing ascorbic acid concentrations in the range of 10-50 g/kg (Van Campen & Gross, 1968; Smith 8~ Bidlack, 1980; Johnson & Murphy, 1988; Van den Berg et al. 1990 ). The present study shows that the feeding of a diet with 5 mg Cu/kg containing only 1 g ascorbic acid/kg for 28 d produced essentially the same effects on tissue Cu concentrations as did supplying a diet with ten times as much ascorbic acid for 42 d. Feeding the high ascorbic acid diet for the longer period only produced slightly greater decreases of Cu concentrations in plasma, liver and other tissues. Thus, tissue Cu concentrations are clearly affected by ascorbic acid intake at levels as low as 0.1 g/kg body-weight.
Dietary ascorbic acid lowered blood haemoglobin concentrations and packed cell volume values (Tables 4 and 6 ). It could be suggested that these effects are caused by ascorbate-induced lowering of tissue Cu concentrations. Diets containing 1 mg Cu/kg not only lowered Cu concentrations in tissues but also caused depressed haemoglobin and packed cell volume (Table 6 ). Anaemia in rats as induced by Cu deficiency has been reported (Johnson & Murphy, 1988) . There was no statistically significant interaction of ascorbic acid and Cu intake with regard to haemoglobin concentrations and packed cell volume, but the effect of high ascorbic acid intake tended to be somewhat more pronounced against a dietary background low in Cu. Such a tendency was also seen concerning growth performance. Final body-weight was reduced only with the combination of high ascorbic acid and low Cu concentrations in the diet (Table 6 ).
Cu absorption It has been suggested (Van Campen & Gross, 1968; Johnson & Murphy, 1988; Van den Berg et al. 1990 ) that dietary ascorbic acid lowers tissue Cu concentrations through interference with the absorption of Cu from intestine. Indeed, in the present study we also found that the apparent absorption of Cu was significantly decreased after feeding a diet supplemented with 1 g ascorbic acid/kg (Table 7) . This may be related to an interaction of ascorbate and Cu at the level of the intestinal lumen. Ascorbate depressed the intestinal absorption of 'j4Cu when the two materials were administered by stomach tube (Van den Berg et al. 1990) . Furthermore, ascorbate reduced the disappearance of "Cu from ligated duodenal segments (Van Campen & Gross, 1968) . If ascorbate depresses intestinal Cu absorption, then retention of orally administered 64Cu should be diminished in rats fed on ascorbic acid. This has indeed been shown earlier (Van Campen & Gross, 1968) . However, we found higher whole-body levels of '.'Cu at each time-point after oral administration of 64Cu in rats fed on ascorbic acid (Fig. l) , while ascorbic acid did not influence calculated true Cu absorption. This might be explained by ascorbate-induced decreased tissue Cu concentrations. Low Cu intake caused an increased apparent absorption of Cu and an enhanced W u retention after intraperitoneal injection of f i 4 C~ (Fig. 2) . Thus, the reduced tissue Cu concentrations as induced by ascorbic acid feeding may have masked effects of ascorbate at the level of intestinal absorption. This would also explain the lack of effect of ascorbate feeding on the recovery of orally administered 64Cu in faeces (Table 5) .
Hepatic uptake of Cu Ascorbate, intravenously administered together with "Cu, caused an increase of "Cu recovery in liver (Table 3 ). This effect of ascorbate was observed at a dose of 0.1 mg/rat. This caused a maximum increase of plasma ascorbate by about 115 ,umol/l, assuming that the rats had about 5 ml plasma. Within this concentration range ascorbate clearly increased Cu uptake by isolated hepatocytes (Table 2) .
Ascorbic acid feeding may also stimulate hepatic Cu uptake because it caused an increase of plasma ascorbate concentrations by about 100 pmol/l (Tables 4 and 6 ). However, no effect on accumulation of 64Cu in liver was observed in rats fed on ascorbic acid and given 64Cu intravenously (Table 5 ). This could be related to the reduced tissue Cu concentrations of rats fed on ascorbic acid. Low Cu intake induces increased efficiency of Cu uptake by various tissues (Van den Berg et al. 1990 ) and increased whole-body retention of "Cu in such rats (Fig. 2) . Thus, circulating ascorbate and decreased cellular Cu concentrations both trigger Cu uptake by cells. Any specific effect of ascorbate on the distribution of "Cu between liver and other tissues after intravenous administration of 64Cu may be masked by reduced concentrations of Cu in extrahepatic tissues. Moreover, the effect of ascorbate on the cellular uptake of Cu may not be specific for liver. Ascorbate has also been shown to stimulate Cu transport from ceruloplasmin into a human erythroleukemic cell line (Percival & Harris, 1989) .
Biliary excretion of Cu
Intravenously administered ascorbate stimulated 64Cu accumulation in bile of rats with a bile duct cannula (Table 3 ). In rats fed on a diet containing 10 g ascorbic acid/kg, more intravenously administered "Cu was recovered in bile than in rats fed on no ascorbic acid ( Table 5 ). In keeping with ascorbate-induced stimulation of biliary Cu excretion, 1 g ascorbic acid/kg in a diet with recommended Cu concentration enhanced the recovery of intraperitoneally administered fi4Cu in faeces (Table 8 ). However, an opposite effect was seen in rats fed on a diet containing 10 g ascorbic acid/kg ( Table 5 ). This may be explained by the Cu-retaining effect of reduced tissue Cu concentrations induced by ascorbate, an effect being more pronounced in rats fed on 10 g instead of 1 g ascorbic acid/kg diet.
The ascorbate-induced stimulation of biliary "Cu excretion seen in Expt 3, and indirectly in Expt 4, probably reflects the increased hepatic uptake of 64Cu and, thus, may be the result of an increased specific activity of Cu in liver pools. This is supported by the observation that in rats fed on ascorbic acid the specific activity of liver Cu was increased by about 30 % (Tables 4 and 5) , while the increase in biliary 64Cu excretion was of the same order of magnitude. Furthermore, it is unlikely that ascorbate promotes biliary excretion of Cu mass because the combination of impaired intestinal absorption of Cu and increased biliary excretion of Cu would not allow for a new steady-state of body Cu to be reached. As a consequence the animals would soon be fully depleted. We speculate that biliary excretion of Cu mass is depressed in rats fed on ascorbic acid. In any event, the ascorbateinduced lowering of tissue Cu concentrations will by itself reduce biliary Cu excretion. This is supported by the observation that low Cu intakes diminish biliary Cu excretion (Owen & Hazelrig, 1968) . In retrospect, it is unfortunate that we did not analyse the amount of Cu in bile fluid samples.
Whole-body retention of " C u
There was a discrepancy in the results for whole-body retention of intraperitoneally injected "Cu in rats fed on recommended Cu diets containing either 10 or 1 g ascorbic acid/kg. In rats fed on a 10 g ascorbic acid/kg diet, the whole-body retention of "Cu was slightly increased (Fig. l) , whereas in rats fed on a 1 g ascorbic acid/kg diet it was slightly decreased (Fig. 2) . This may relate to the somewhat different tissue Cu concentrations in rats fed on the two ascorbate diets. Retention of intraperitoneally injected 64Cu essentially refers to 64Cu accumulated by cells minus urinary excretion of 64Cu and non-reabsorbed "Cu excreted in bile. As shown earlier (Van den Berg et al. 1990) , and in the present study (Fig. 2) , low Cu intake increases 64Cu retention, probably by stimulating cellular uptake of Cu (Van den Berg et al. 1990, 1991) . Ascorbate, on the other hand, tends to decrease 'Wu retention through increased biliary excretion of fi4Cu. Apparently, in rats fed on the diet containing 10 g ascorbic acid/kg for 42 d (Fig. 1 ) the net effect of ascorbate-induced lowering of tissue Cu concentrations and increased biliary excretion results in enhanced 64Cu retention. In other words, the effect of reduced tissue Cu concentrations overrules that of circulating ascorbate. The opposite may hold for Cu retention (Fig. 2) in rats fed on the recommended Cu diet containing 1 g ascorbic acid/kg.
Conclusions
It has been shown that dietary ascorbic acid concentrations of 1 and 10 g/kg reduce tissue Cu concentrations in rats. Ascorbate interfered with intestinal Cu absorption. Ascorbate also stimulated hepatic uptake of 64Cu. This may be responsible for the observed ascorbateinduced enhancement of biliary excretion of intravenously administered 'j4Cu, although this should not necessarily be associated with an increased biliary excretion of Cu mass. Evidence is presented that, when studying the mechanism underlying the lowering of tissue Cu concentrations by ascorbic acid feeding, the primary effects of ascorbate itself and the secondary effects of the ascorbate-induced reduced tissue Cu concentrations should be distinguished.
